Anti-babesial compounds from Curcuma zedoaria

Area of Science:

• Natural Product Chemistry
• Parasitology
• Veterinary Medicine

Background:

• Babesiosis is a tick-borne parasitic disease affecting animals, causing significant economic losses.
• Current treatments for babesiosis have limitations, necessitating the search for novel therapeutic agents.
• Curcuma zedoaria, a traditional medicinal plant, has shown potential in preliminary studies.

Purpose of the Study:

• To investigate the anti-babesial activity of Curcuma zedoaria bark extract.
• To isolate and identify the active compounds responsible for the anti-babesial effect.
• To compare the efficacy of these compounds with a standard anti-babesial drug.

Main Methods:

• Extraction of Curcuma zedoaria bark.
• Isolation and structural elucidation of active compounds using spectral data.
• In vitro testing of isolated compounds against Babesia gibsoni.
• Determination of IC50 values and comparison with diminazene aceturate.

Main Results:

• An extract of Curcuma zedoaria bark exhibited significant anti-babesial activity.
• Three active compounds, zedoalactones A, B, and C, were isolated and identified.
• Zedoalactone C was a novel compound.
• Zedoalactones A, B, and C showed IC50 values of 16.5, 1.6, and 4.2 microg/mL, respectively, against Babesia gibsoni.
• Zedoalactone B demonstrated the most potent activity among the isolated compounds, though less potent than the standard drug diminazene aceturate (0.6 microg/mL).

Conclusions:

• Curcuma zedoaria bark contains compounds with potent anti-babesial activity.
• Zedoalactones A, B, and C are promising candidates for further development as anti-babesial agents.
• Further research is warranted to explore the therapeutic potential of these zedoalactones in treating babesiosis.